iCUREX is a medical-device startup and develops and commercializes medical devices using chitosan hydrogel technology.
iCUREX has raised $634K in total funding. The most recent round was Series A. The last funding was announced in October 2026.
iCUREX's investors include INDEP, Japan Finance Corporation, NCB Venture Capital, Green Core.
iCUREX is headquartered in Kagoshima, Japan.
iCUREX is a medical-device startup and develops and commercializes medical devices using chitosan hydrogel technology.
iCUREX is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"iCUREX — Funding & Investors." VCBacked, October 22, 2026, https://www.vcbacked.co/company/icurex. Accessed November 12, 2026.
VCBacked. (2026). iCUREX — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/icurex
{{cite web |title=iCUREX — Funding & Investors |url=https://www.vcbacked.co/company/icurex |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at iCUREX? Request a listing update